Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 1000 for query «pharma»

23 June, 2017 5:43 AM Helios Cap's Samir Arora is nervous about midcaps; is short on pharma, tech, telecom

Helios Cap’s founder and fund manager believes that June has been a good month so far. He also keeps an eye on the fund flows by investors as they cannot be completely relied on yet. With the market going through a slight consolidation amidst what has otherwise been a bull run, Helios Capital’s Founder and Fund Manager Samir Arora believes that nothing 20

22 June, 2017 5:53 AM Market Live: Sensex hits fresh record high of 31500, Nifty eyes 9700; Infosys leads

11:27 am Buzzing:Â Shares prices of dairy products makers Prabhat Dairy, Parag Milk Foods and Vadilal Industries gained as much as 4-9 percent in morning trade after the ban on milk products from the world's second largest economy. The Government of India today has banned milk, milk products and confectionary from China for one year, reports CNBC-TV 28

21 June, 2017 6:03 AM Alembic Pharma surges 4% on USFDA approval for hypertension drug

Shares of Alembic Pharmaceuticals surged 4.2 percent intraday Wednesday as it has received USFDA nod for Candesartan Cilexetil Tablets. The company has received approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Candesartan Cilexetil Tablets 32mg. The approved equivalent to the reference 31

21 June, 2017 4:36 AM Buy AB Nuvo, Godrej Consumer; sell Zee Ent, Bata, Glenmark: Mitessh Thakkar

Mitessh Thakkar of recommends buying Aditya Birla Nuvo and Godrej Consumer and advises selling Zee Entertainment, Bata India and Glenmark Pharma. Mitessh Thakkar of told CNBC-TV18, "I have a mix of buy and sell calls. The first one is a buy call on Aditya Birla Nuvo with a stop loss at Rs 1,680, look for target of Rs 1,740. The second 25

21 June, 2017 12:30 AM ‘Docs need awareness of adverse drug reactions’

Visakhapatnam: The pharmacology department of Andhra Medical College (AMC) organised a continuous medical education (CME) programme on pharmaco-vigilance under the aegis of National Coordination Centre Pharmaco-vigilance programme of India (PVPI) on Tuesday to sensitise doctors and clinicians on drug reactions. Around 3.7% of all patients visiting the out-patient 42

20 June, 2017 7:44 AM Buy Balkrishna Industries, Dabur India: Mitessh Thakkar

Mitessh Thakkar of advises buying Balkrishna Industries and Dabur India. Mitessh Thakkar of told CNBC-TV18, "I have been positive on the metals pack. Tata Steel was a recommendation yesterday. JSW Steel could see some follow-up along with Tata Steel maybe Hindalco. Hindalco is something which I am not very bullish 22

16 June, 2017 6:56 PM Consumer-facing companies stare at over a month’s sales loss due to GST

Generate Enquiries for your Business by Listing on ET INTELLIGENCE GROUP: Indian companies that rely on elaborate distribution networks to reach out to their customers face an unexpected headwind – the GST. Introduction of the new levy, billed as India’s biggest indirect-tax reform since Independence, may cause about 45 days of potential 42

16 June, 2017 6:20 AM Buy BPCL, India Cements, UPL; Aurobindo Pharma may hit Rs 700: Ashwani Gujral

According to Ashwani Gujral of, one can buy BPCL, India Cements and UPL and feels that Aurobindo Pharma may test Rs 700. Ashwani Gujral of told CNBC-TV18, "Aurobindo Pharma is going through a sharp rally and Rs 700 is the 200-day moving average, so, that is a nice target. It is possible that it has bottomed out but possibly 22

16 June, 2017 2:57 AM Ganeshaspeaks: Nifty prediction for June 16

Please consider 10 minutes plus and minus in each prediction, and act accordingly. Ganesha advises you to compare every prediction with the prediction of the previous time slot. Today Mahanagar Telecom, Hydropower companies, SREI Infra and Aarvee Denim shall be in the news. Adani Transmission, Natco Pharma, Greenply Industries, Sunteck Realty, MMTC and Pidilite 22

15 June, 2017 5:32 AM Keep two years' view on RIL to make good money out of it: Deven Choksey

In an interview to CNBC-TV18, Deven Choksey, MD of KR Choksey Investment Managers shared his views on public sector banks, Reliance Industries Ltd (RIL), IT and pharma. In an interview to CNBC-TV18, Deven Choksey, MD of KR Choksey Investment Managers shared his views on public sector banks, Reliance Industries Ltd (RIL), IT and pharma. He believes that banking 19